Commercials often paint an idyllic picture of biologics as life-changing medications, portraying idyllic scenes of joy and togetherness, while downplaying the potential for significant side effects. This raises an important question: What is the true efficacy of biologics? Consider the potential of pinpointing the optimal biologic from the start, or determining its effectiveness for an individual, thus sidestepping the risk of adverse effects. Pre-treatment evaluation of a patient's response to a therapy allows for a more strategic use of healthcare funds by plans and sponsors. Lena Chaihorsky, co-founder of Payer Innovation at Alva10, has pioneered technology to make this a reality. Tune in to our enlightening discussion on how healthcare plans can embrace precision medicine to reduce the costs of ineffective biologic treatments, ensuring patients receive the most effective care. #biologics #precisionmedicine #employeebenefits #prescriptiondrugs #healthplans #humira #enbrel #remicade #stelara #skyrizi #tremfya